Friday, October 06, 2017 10:49:35 AM
I read the documents correspondence back and forth and the "Final Rejection" response from PTO on 9-28-16 explains why it was rejected for a couple of reasons.
The specific products Dr. Blair, et al are claiming in steps 1 - 4 have already been "claimed" by prior applicants and their technology; Jakobsson in 2002 and Zeikus, et al (Patent # 4,403,032)from similar processes, albeit with enzymes. The focus is on identifying what the specific end reaction product(s) is and percentages. Since someone beat them to it, they can not make a specific product claim for their reaction product, therefore not allowing them to strengthen their patent around the CTS technology. Additionally, the patent reviewer also goes on to cite "non-statutory double-patenting" as the general claims in the new application mirror what was already stated in the issued original patent, 8062428.26 b2, and further supports rejection of this application. From a litigation or enforcement standpoint, this seems huge as anyone can design and operate a similar process, just slightly different, but achieve the same end product. Sounds like anyone could duplicate their CTS process and just add a drop of water to the reactor and the ALLM patent would be useless, since it is based on a "non-aqueous" reaction of solid acid catalyst and material.
So if all they are left with is general claims of making sugars as an end product from CTS process, it doesn't seem like the patent is all that strong or enforceable from a licensing standpoint. This would explain why no license agreements or bolt-ons or plants built in 4 years.
The further you dig, the more clearer things become...Thanks
Recent BIOF News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 05:02:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/24/2024 04:55:41 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 05/20/2024 05:53:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:26:21 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 08:19:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 02:34:54 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 05:41:18 PM
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM